Ikena Oncology
IKNA
1,24 €
Share price
4.38%
Change (1 day)
-22.16%
Change (1 year)
Categories
Ikena Oncology (IKNA) - P/B ratio
P/B ratio as of July 2025 : 0.5066
According to Ikena Oncology's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Ikena Oncology - P/B ratio (from 2021 to 2025)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2025-12-31 | N/A | -100% |
| 2024-12-31 | 0.5901 | 5.38% |
| 2023-12-31 | 0.5600 | -24.02% |
| 2022-12-31 | 0.7371 | -69.79% |
| 2021-12-31 | 2.44 | |
| 2020-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 4.28 | 745.19% | 🇺🇸 USA |